Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease

Reproduction

Volumn 135, Issue 5, 2008, Pages 713-721

  Nilsson, Eric E ^a   Anway, Matthew D ^a   Stanfield, Jacob ^a   Skinner, Michael K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VINCLOZOLIN;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FEMALE; GENETIC EPIGENESIS; GLOMERULOPATHY; KIDNEY BIOPSY; MATERNAL DISEASE; NONHUMAN; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RAT; SEX DETERMINATION; UTERUS BLEEDING;

AGE OF ONSET; ANIMALS; BRAIN NEOPLASMS; BREEDING; ENDOCRINE DISRUPTORS; EPIGENESIS, GENETIC; FEMALE; FUNGICIDES, INDUSTRIAL; KIDNEY DISEASES; KIDNEY NEOPLASMS; MALE; MATERNAL EXPOSURE; OXAZOLES; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, CHRONIC;

ANIMALIA; RATTUS;

EID: 43549095493     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/REP-07-0542     Document Type: Article

References (30)

1. Anway MD & Skinner MK 2006 Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147 S43-S49.
2. Anway MD, Cupp AS, Uzumcu M & Skinner MK 2005 Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 1466-1469.
3. Anway MD, Leathers C & Skinner MK 2006a Endocrine disrupter vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147 5515-5523.
4. Anway MD, Memon MA, Uzumcu M & Skinner MK 2006b Transgenerational effect of the endocrine disrupter vinclozolin on male spermatogenesis. Journal of Andrology 27 868-879.
5. Barber R, Plumb MA, Boulton E, Roux I & Dubrova YE 2002 Elevated mutation rates in the germ line offirst- and second-generation offspring of irradiated male mice. PNAS 99 6877-6882.
6. Bjornsson HT, Fallin MD & Feinberg AP 2004 An integrated epigenetic and genetic approach to common human disease. Trends in Genetics 20 350-358.
7. Blatt J, Van Le L, Weiner T & Sailer S 2003 Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. Journal of Pediatric Hematology/Oncology 25 635-636.
8. Chang HS, Anway MD, Rekow SS & Skinner MK 2006 Transgenerational epigenetic imprinting ofthe male germline by endocrine disrupter exposure cluringgonadal sex determination. Endocrinology 147 5524-5541.
9. Corwin EJ 2004 The concept of epigenetics and its role in the development of cardiovascular disease: Commentary on 'new and emerging theories of cardiovascular disease'. Biological Research for Nursing 6 11-16 (discussion 21-3).
10. Cupp AS, Uzumcu M, Suzuki H, Dirks K, Phillips B & Skinner MK 2003 Effect of transient embryonic in vivo exposure to the endocrine disrupter methoxychlor on embryonic and postnatal testis development. Journal of Andrology 24 736-745.
11. Drake AJ, Walker BR & Seckl JR 2005 Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 R34-R38.
12. Egger G, Liang G, Aparicio A & Jones PA 2004 Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 457-463.
13. Fisher JS 2004 Environmental anti-androgens and male reproductive health: Focus on phthalates and testicular dysgenesis syndrome. Reproduction 127 305-315.
14. Gluckman PD & Hanson MA 2004 Developmental origins of disease paradigm: A mechanistic and evolutionary perspective. Pediatric Research 56 311-317.
15. Gray LE Jr, Ostby J, Monosson E & Kelce WR 1999 Environmental antiandrogens: Low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicology and Industrial Health 15 48-64.
16. Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ & Ward RL 2007 Inheritance of a cancer-associated MLH1 germ-line epimutation. New England Journal of Medicine 356 697-705.
17. Hotchkiss AK, Ostby JS, Vandenburgh JG & Gray LE Jr 2002 Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague-Dawley rat. Environmental Health Perspectives 110(Suppl3) 435-439.
18. Kelce WR, Monosson E, Gamcsik MP, Laws SC & Gray LE Jr 1994 Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicology and Applied Pharmacology 126 276-285.
19. Kubota Y, Umegaki K, Kagota S, Tanaka N, Nakamura K. Kunitomo M & Shinozuka K 2006 Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biological & Pharmaceutical Bulletin 29 1756-1758.
20. Redman CW & Sargent IL 2005 Latest advances in understanding preeclampsia. Science 308 1592-1594.
21. Reynolds RM, Godfrey KM, Barker M, Osmond C & Phillips DI 2007 Stress responsiveness in adult life: Influence of mother's diet in late pregnancy. Journal of Clinical Endocrinology and Metabolism 92 2208-2210.
22. Roberts JM & Lain KY 2002 Recent insights into the pathogenesis of preeclampsia. Placenta 23 359-372.
23. Ronco P & Debiec H 2006 New insights into the pathogenesis of membranous glomerulonephritis. Current Opinion in Nephrology and Hypertension 15 258-263.
24. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H, Ko MS, Chlsson R, Longo DL & Feinberg AP 2005 Loss of imprinting of lgf2 alters intestinal maturation and tumorigenesis in mice. Science 307 1976-1978.
25. Sibai BM 2003 Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics and Gynecology 102 181-192.
26. Signore C, Mills JL, Qian C, Yu K, Lam C, Epstein FH, Karamanchi SA & Levine RJ 2006 Circulating angiogenic factors and placental abruption. Obstetrics and Gynecology 108 338-344.
27. Stockham SL & Scott MA 2002 Fundamentals of Veterinary Clinical Pathology, pp 1-610. Ames, IA: Iowa State Press.
28. Uzumcu M, Suzuki H & Skinner MK 2004 Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reproductive Toxicology 18 765-774.
29. Wolf CJ, LeBlanc GA, Ostby JS & Gray LE Jr 2000 Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicological Sciences 55 152-161.
30. Zambrano E, Martinez-Samayoa PM, Bautista CJ, Deas M, Guillen L, Rodriguez-Gonzalez GL, Guzman C, Larrea F & Nathanielsz PW 2005 Sex differences in transgenerational alterations of growth and metabolism in progeny (F2) of female offspring (F1) of rats fed a low protein diet during pregnancy and lactation. Journal of Physiology 566 225-236.